Tag Yoshifumi Noda M.D.

Introduction Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of less than 10%, and accounts for 90% of all pancreatic tumors. It remains one of the most difficult challenges in oncology because patients are typically…